Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report
Abstract Rapid and reliable identification of targetable driver mutations in patients with advanced stage lung cancer is essential. Adequate amount of tumor tissue biopsies (i.e., genomic biopsies) are required to successfully analyze the gene panel. In the present case, we performed three pleural f...
Main Authors: | Kei Kunimasa, Takako Inoue, Yugo Kai, Ryu Kanzaki, Sachi Kawagishi, Ken‐ichi Yoshida, Keiichiro Honma, Motohiro Tamiya, Takahisa Kawamura, Kazumi Nishino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14738 |
Similar Items
-
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study
by: Kei Kunimasa, et al.
Published: (2023-12-01) -
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report
by: Takako Inoue, et al.
Published: (2024-04-01) -
Comparison of sampling methods for next generation sequencing for patients with lung cancer
by: Kei Kunimasa, et al.
Published: (2022-07-01) -
Driver mutation detected in cerebrospinal fluid despite negative liquid biopsy results
by: Kei Kunimasa, et al.
Published: (2025-02-01) -
Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report
by: Kei Kunimasa, MD, PhD, et al.
Published: (2023-01-01)